Overview

Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen

Status:
Unknown status

Trial end date:
2010-11-01

Target enrollment:

Participant gender:

Summary

The objective of the study is to confirm that the efficacy of vaginal progesterone is at least as good as oral progesterone in order to protect the endometrium of uncontrolled proliferation and prevent endometrial cancer.

Phase:

Phase 2

Details

Lead Sponsor:

Rabin Medical Center

Collaborator:

Ferring Pharmaceuticals

Treatments:

Estradiol
Estrogens
Norethindrone acetate
Progesterone